CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid Malignancies
Clinical trial NCT03121625 · UNKNOWN
Trial details
- NCT number
- NCT03121625
- Sponsor
- Hebei Senlang Biotechnology Inc., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-26
- Primary completion
- 2018-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.